Current:Home > StocksDrugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations-InfoLens
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations
View Date:2024-12-23 11:26:24
The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications to treat diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026.
The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, which is used to treat blood cancers. That is the medication’s cost before any discounts or rebates are applied, but not what the price people actually pay when filling their prescriptions.
A look at the drugs and the negotiated prices.
Januvia
Manufacturer: Merck Sharp Dohme
Conditions: Diabetes
Negotiated price: $113 for a 30-day supply
Reduction: 79%
Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill:
Manufacturer: Novo Norodisk
Conditions: Diabetes
Negotiated price: $119 for a 30- day supply
Reduction: 76%
Farxiga
Manufacturer: AstraZeneca AB.
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $178.50 for a 30-day supply
Reduction: 68%
Enbrel
Manufacturer: Immunex Corp.
Conditions: Rheumatoid arthritis, psoriasis and psoriatic arthritis
Negotiated price: $2,355 for a 30-day supply
Reduction: 67%
Jardiance
Manufacturer: Boehringer Ingelheim
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $197 for a 30-day supply
Reduction: 66%
Stelara
Manufacturer: Janssen Biotech Inc.
Conditions: Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis
Negotiated price: $4,695 for a 30-day supply
Reduction: 66%
Xarelto
Manufacturer: Janssen Pharms
Conditions: Prevention and treatment of blood clots. Reduction of risk for patients with coronary or peripheral artery disease
Negotiated price: $197 for a 30-day supply
Reduction: 62%
Eliquis
Manufacturer: Bristol Myers Squibb
Conditions: Prevention and treatment of blood clots
Negotiated price: $231 for a 30-day supply
Reduction: 56%
Entresto
Manufacturer: Novartis Pharms Corp
Conditions: Heart failure
Negotiated price: $295 for a 30-day supply
Reduction: 53%
Imbruvica
Manufacturer: Pharmacyclics LLC
Conditions: Blood cancers
Negotiated price: $9,319 for a 30-day supply
Savings: 38%
veryGood! (65)
Related
- 3 Iraqis tortured at Abu Ghraib win $42M judgement against defense contractor
- Gigi Hadid Shares Rare Look at 4-Year-Old Daughter Khai in New Photos
- Home Depot founder Bernard Marcus, Trump supporter and Republican megadonor, has died
- A pivotal Nevada Senate race is unusually quiet for the battleground state
- Massachusetts lawmakers to consider a soccer stadium for the New England Revolution
- Alaska voters deciding a hard-fought race for the state’s only U.S. House seat, election issues
- Which is the biggest dinner-table conversation killer: the election, or money?
- New Hampshire’s governor’s race pits ex-Sen. Kelly Ayotte against ex-Mayor Joyce Craig
- 'Gladiator 2' review: Yes, we are entertained again by outrageous sequel
- Kristin Cavallari Wants Partner With a Vasectomy After Mark Estes Split
Ranking
- Bitcoin has topped $87,000 for a new record high. What to know about crypto’s post-election rally
- Add These Kate Spade Outlet Early Black Friday Deals to Your Cart STAT – $51 Bags & Finds Start at $11
- What It's Really Like Growing Up As First Kid in the White House
- Sign of the times in front yard political wars: A campaign to make America laugh again
- Rep. Michael McCaul of Texas says he was detained in airport over being ‘disoriented’
- Nebraska adds former coach Dana Holgorsen as offensive analyst, per report
- Sign of the times in front yard political wars: A campaign to make America laugh again
- NFL trade deadline grades: Breaking down which team won each notable deal
Recommendation
-
Nevada Democrats keep legislative control but fall short of veto-proof supermajority
-
TGI Fridays bankruptcy: Are more locations closing? Here’s what we know so far
-
Democrats hope to keep winning streak alive in Washington governor’s race
-
Beyoncé Channels Pamela Anderson in Surprise Music Video for Bodyguard
-
Crews battle 'rapid spread' conditions against Jennings Creek fire in Northeast
-
Charges against South Carolina women's basketball's Ashlyn Watkins dismissed
-
10 teams to watch as MLB rumors swirl with GM meetings, free agency getting underway
-
Connecticut to decide on constitution change to make mail-in voting easier